Zinger Key Points
- Cigna reported lower-than-expected Q4 earnings due to higher medical costs, causing an initial stock drop before rebounding on Friday.
- Despite the earnings miss, revenue grew 27% year-over-year and Cigna increased its share repurchase program by $6 billion.
- Get the Real Story Behind Every Major Earnings Report
Cigna Group inc. CI shares are rebounding Friday after dropping on Thursday following a fourth-quarter earnings miss.
What To Know: Cigna reported fourth-quarter revenue of $65.68 billion, exceeding analyst estimates of $63.36 billion, but missed on earnings with an adjusted EPS of $6.64 versus expectations of $7.82. The earnings shortfall was driven by higher stop-loss medical costs, which contributed to an 8% decline in adjusted income from operations.
Despite the earnings miss, revenue grew 27% year-over-year, led by increases in pharmacy benefit services and specialty care. The company also announced a $6 billion increase to its share repurchase program, bringing total authorization to $10.3 billion.
Cigna provided 2025 guidance, expecting at least $252 billion in revenue, slightly above estimates. However, full-year adjusted EPS guidance of at least $29.50 fell short of analysts’ expectations of $31.50.
Shares initially dropped 11.1% on Thursday but are rebounding potentially as investors focus on management's corrective actions and long-term strategy.
CI Price Action: Cigna Group shares were up 4.97% at $297.04 at the time of writing, according to Benzinga Pro.
Read Next:
Image Via Shutterstock.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.